Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

SURMODICS INC Director's Dealing 2018

Nov 29, 2018

32845_dirs_2018-11-29_6999e973-550a-4e91-b722-53f61f542f79.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: SURMODICS INC (SRDX)
CIK: 0000924717
Period of Report: 2018-11-27

Reporting Person: Greaney Thomas A. (COO of Medical Devices)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2018-11-27 Common Stock A 2648 $0.00 Acquired 9879 Direct
2018-11-27 Common Stock A 8711 $0.00 Acquired 18590 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2018-11-27 Employee Stock Option (right to buy) $56.63 A 12292 Acquired 2025-11-27 Common Stock (12292) Direct

Footnotes

F1: Shares issued in connection with the vesting of a performance share award under long-term incentive plan based on performance during three-year period ended September 30, 2018.

F2: The award vests in four equal installments on each of the first four anniversaries of the November 27, 2018 grant date.